Clinical Trial Update: ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ARX788 in HER2-positive metastatic breast cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer with Brain Metastases

Drugs mentioned

• ARX788

Snippet

Sponsor: Fudan University | Conditions: HER2-positive, Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN